Quinoline and coumarin isoxazole derivatives: synthesis, antitumor evaluation and molecular docking studies with Bcl-2
Martina Piškor, Marina Ter, Leentje Persoons, Dirk Daelemans, Ahmed Adel, Mutasem O. Taha, Astrid Milić, Mirela Sedić, Silvana Raić-Malić · 2025
Read Quinoline and coumarin isoxazole derivatives: synthesis, antitumor evaluation and molecular docking studies with Bcl-2 by Martina Piškor, Marina Ter, Leentje Persoons, Dirk Daelemans, Ahmed Adel, Mutasem O. Taha, Astrid Milić, Mirela Sedić, Silvana Raić-Malić (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12709234.txt.
Description
Martina Piškor and eight co-authors made new compounds aimed at cancer cell death, in a 2025 paper. Some cancers resist standard drugs, so new agents are needed. The team built compounds from three known chemical families. Some versions were paired with metals. They tested the set on eight human cancer cell lines and on healthy blood cells.
One compound stood out for strong effects at low doses. It hit blood cancers and a pancreas cancer line hard. It spared healthy cells far more than cancer cells. Tests showed it crossed cell walls well and broke down at a moderate rate. Computer fits showed it binds tightly to a protein that helps cancer cells avoid death. The authors name it a lead for further drug work.
Catalog record
| CREATOR | Martina Piškor, Marina Ter, Leentje Persoons, Dirk Daelemans, Ahmed Adel, Mutasem O. Taha, Astrid Milić, Mirela Sedić, Silvana Raić-Malić |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 71 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |